Sponsor:
NasaClip
Code:
NCT05789264
Conditions
Epistaxis Nosebleed
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Nasal Compression Device
Routine Care
Brief summary:
Conditions
Epistaxis Nosebleed
Study ID
NCT05789264
Start date
Sep 26, 2023
Status verified date
Nov, 2023
Completion date
Jun, 2024
Anticipated
Primary completion date
May, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Standard of Care
experimental: Nasal Compression Device
Interventions
Nasal Compression Device
Routine Care
Primary outcome measure
Central contacts
Locations
Next Level Urgent Care
Recruiting
Houston, Texas, United States, 77057
Contacts
Sponsor
NasaClip
Last update posted
Nov 22, 2023
Last verified
Nov, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by NasaClip on 2023-11-22.